CASSANDRA MCCURDY: Open Payments
NPI 1437179660 · MANTECA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 14 payments from 12 companies in 2025. Trend: 2023 $1,050 · 2024 $736 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Axsome Therapeutics, Inc. | 1 | $110 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $85 |
| Vanda Pharmaceuticals Inc. | 2 | $48 |
| ABBVIE INC. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $31 |
| Exact Sciences Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Eisai Inc. | 1 | $16 |
Products named: REXULTI, Auvelity, Kerendia, HETLIOZ, VRAYLAR, AIRSUPRA, Cologuard Collection Kit, FREESTYLE LIBRE 3.
Industry payments across CA — which companies pay providers there.
